Earnings Outlook For Anika Therapeutics
Portfolio Pulse from Benzinga Insights
Anika Therapeutics (NASDAQ:ANIK) is scheduled to release its quarterly earnings report on March 13, 2024, with analysts expecting an EPS of $-0.26. The company's past earnings performance shows a mix of beats and misses, with the last quarter beating estimates by $0.37, leading to an 11.22% share price increase the following day. Shares are currently trading at $25.79, down 3.27% over the last year. Investors are looking for positive guidance for the next quarter.
March 12, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Anika Therapeutics is expected to report an EPS of $-0.26 for the upcoming quarter. The company's stock performance has been negative over the last year, with a 3.27% decrease. Investors are hopeful for positive future guidance.
Given Anika Therapeutics' mixed past earnings performance and the recent decrease in stock value, the upcoming earnings report and particularly the future guidance provided by the company will be crucial for short-term stock movement. The expectation of an EPS of $-0.26 sets a cautious tone, but as past performance shows, a beat on expectations and positive guidance could lead to significant price movements. However, the recent downward trend in stock price and the uncertainty surrounding the guidance make the short-term impact neutral until the earnings are released.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100